Claritas Pharmaceuticals

Claritas and CMAX Clinical sign agreement for Phase 1 R-107 clinical study
Pharmaceutical Business Review
Thu, 04/22/21 - 10:57 am
Claritas Pharmaceuticals
CMAX
clinical trials
R-107